Taj Worldwide | Taj Group | Media | Career | FAQs | Feedback | contact us
 
Taj Logo
especially Products
 
Quality Medicines Api Generic Manufacturing For Doctors Brands Newsroom
 

Tozol-20 ® Taj Products

 
HOME >> PRODUCTS >> Taj Products >> Tozol-20
Taj  ALL Products View Products According to Category


Each capsule (E.C. granules ) contains
Composition


Omeprazol..................................................................20 mg

Indications
Ulcer, duodenal; Adenoma, multiple endocrine; Esophagitis, erosive; Gastroesophageal Reflux Disease; Mastocytosis, systemic; Ulcer, gastric; Zollinger-Ellison syndrome; Pregnancy Category C

Description
Omeprazole is a selective and irreversible proton pump inhibitor. Omeprazole suppresses gastric acid secretion by specific inhibition of the hydrogen–potassium adenosinetriphosphatase (H +, K +-ATPase) enzyme system found at the secretory surface of parietal cells. It inhibits the final transport of hydrogen ions (via exchange with potassium ions) into the gastric lumen. Since the H +, K +-ATPase enzyme system is regarded as the acid (proton) pump of the gastric mucosa, omeprazole is known as a gastric acid pump inhibitor. The inhibitory effect is dose-related. Omeprazole inhibits both basal and stimulated acid secretion irrespective of the stimulus.

Side/Adverse Effects
Note: Gastric fundic gland polyps have occurred rarely in patients receiving omeprazole; these appear to be benign and reversible upon discontinuance of omeprazole.
Gastroduodenal carcinoids have been reported in patients with Zollinger-Ellison syndrome who have received long-term omeprazole therapy. These carcinoids are believed to be a manifestation of the underlying syndrome, which is known to be associated with such tumors.
Atrophic gastritis has been noted occasionally in gastric corpus biopsies from patient receiving long-term omeprazole therapy.

Overt liver disease has occurred rarely, and included hepatocellular, cholestatic, or mixed hepatitis, liver necrosis (sometimes fatal), hepatic failure (sometimes fatal), and hepatic encephalopathy.

The following side/adverse effects have been selected on the basis of their potential clinical significance (possible signs and symptoms in parentheses where appropriate)—not necessarily inclusive

Contraindications
Omeprazole delayed-release capsules are contraindicated in patients with known hypersensitivity to any component of the formulation

Dosage
As per the physician’s advice.

Presentations
10 caps

 


Note : This product information is intended only for residents of the India. Taj Pharmaceuticals Limited,  medicines help to treat and prevent a range of conditions—from the most common to the most challenging—for people around the world.

Information for Health Care Professionals

*** Please consult local Prescribing Information for any product before use. This website is an international information resource for healthcare professionals with an interest in disease management. This website is not intended to replace the advice of a qualified healthcare professional. Above brand is a trademark of the Taj group of companies (Taj Pharmaceuticals Limited)

 



 

Tozol-20 ®

 

Tozol-20





 










 

 

 

 

 

 

 


              
 Print page   Send by mail


 

   
   
PRODUCTS
 
 
   
   
   
  india flag
  The Taj Pharmaceuticals Limited (Taj Group) has operations in every major international market
    AFRICA
  ASIA PACIFIC
  EUROPE
  MIDDLE EAST
  THAILAND
  BANGLADESH
  NORTH AMERICA
  SOUTH AMERICA
  RUSSIA
  NEWZELAND
  UNITED KINGDOM
 

   

 

 

 

 

 

 

 


 

 
 www.tajpharma.com

   

 

About Taj

Company

Products Diseases Health Divisions Media R & D Sustainability
Figure & Reports Investors

Countries

Brochure E-mail us Export & Import
Vacancies | C & F Agency | Distributor | Group Companies | History | Enquire Form | Countries | Pharma Technology
 Contact | Sitemap | User Terms and Conditions | Privacy and Cookie Statement